Repro Med taps Narishkin as new prez
Repro-Med Systems said last month it appointed Cyril Narishkin as its new president, replacing Andrew Sealfon. Sealfon will stay on as chief executive officer and head of research and development.
More recent news
- A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
- Dexcom continues advances in AI for CGM, type 2 diabetes awareness
- Tandem continues to deliver more options, benefits for those with diabetes
- Breaking: Sequel to launch twiist automated insulin delivery system next month
- Dexcom shares U.S. report on CGM benefits for type 2 diabetes
